-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

906. Outcomes Research—Myeloid Malignancies: Poster III

Symposia: Outcomes Research—Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Scott Patrick Tisoskey, BS1*, Douglas William Ford, BS2* and Patricia A. Locantore-Ford, MD3

1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Harvard Medical School, Harvard University, Cambridge, MA
3Abramson Cancer Center, Pennsylvania Hospital, Philadelphia, PA

Gin Yi Lee1*, Clare Huang2* and Kevin Sheng-Kai Ma2*

1Brigham and Women`s Hospital, BOSTON, MA
2Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA

Pinkal Desai, MD, MPH1, Jacqueline S. Garcia, MD2, Joshua F. Zeidner, MD3, Sameem Abedin, MD4, Ofir Wolach5*, Pankit Vachhani, MD6, Yakir Moshe, MD, PhD7*, Daniel A. Pollyea, MD8*, Catherine Lai, MD9, Thomas W LeBlanc, MD10, Marin Xavier, MD11, Boaz Nachmias, MD12*, Evan C. Chen, MD13, Srilakshmi Bathini6, Inderpreet Bhatti14*, Cat N. Bui, PharmD, PhD15*, Annie Guérin, MS16*, Rebecca Burne17*, Esprit Ma, MPH18*, Moshe Grunspan19*, Neta Frankel19* and Aaron D. Goldberg, MD, PhD20

1Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY
2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
3University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
4Medical College of Wisconsin, Milwaukee, WI
5Rabin Medical Center, Petah Tikva, Israel
6O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
7Division of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
8University of Colorado School of Medicine, Aurora, CO
9Abramson Cancer Center, Georgetown University Hospital, Washington, DC
10Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
11Scripps Health, San Diego, CA
12Hebrew University, Jerusalem, Israel
13Dana Farber Cancer Institute, Boston, MA
14Scripps MD Anderson, San Diego, CA
15AbbVie Inc, North Chicago, IL
16Analysis Group, Inc, Montreal, Canada
17Analysis Group Inc, Montreal, Canada
18Genentech, Inc., South San Francisco, CA
19AbbVie Inc, Hod Hasharon, Israel
20Memorial Sloan Kettering Cancer Center, New York City, NY

Vikas Gupta, MD, FRCP1*, Paola Guglielmelli, MD, PhD2, JE Hamer-Maansson, MSPH3*, Evan M. Braunstein, MD, PhD3* and Haifa Kathrin Al-Ali, MD/Prof4*

1Princess Margaret Cancer Centre, Toronto, ON, Canada
2Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
3Incyte Corporation, Wilmington, DE
4Krukenberg Cancer Center Halle, University Medicine Halle, Halle, Germany

Adam Suleman, MD1, Sho Podolsky2*, Ning Liu, PhD2*, Kelvin KW Chan, MD, PhD2,3*, Sumedha Arya, MD4*, Lisa Hicks, MD5, Matthew C. Cheung, MD, MSc2,6 and Anca Prica, MD7

1Department of Medicine, University of Toronto, Toronto, ON, Canada
2Institute for Clinical Evaluative Sciences (ICES), Toronto, Canada
3Sunnybrook Health Sciences Centre, Toronto, Canada
4Canadian Blood Services, Toronto, ON, CAN
5Division of Hematology-Oncology, St. Michael's Hospital, Toronto, ON, Canada
6Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
7Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada

Cassandra Duarte, MD1, Diana Abbott, PhD2, Grace N Bosma, MS3*, Christine M. McMahon4, Jonathan A Gutman, MD2, Marc Schwartz, MD5*, Daniel Pollyea2 and Maria L Amaya, MD, PhD2

1University of Colorado Cancer Center, Denver, CO
2University of Colorado, Aurora, CO
3Division of Hematology, University of Colorado School of Medicine, Aurora, CO
4University of Colorado School of Medicine, Aurora, CO
5Division of Hematology, University of Colorado, Aurora, CO

Charanpreet Singh, MD, MBBS, DM1*, Manpreet Saini, MBBS1*, Arihant Jain, MD, DM1*, Deepesh Pravinkumar Lad, MD, DM1, Gaurav Prakash, MD, DM1*, Alka Rani Khadwal, MD1*, Shano Naseem, MD2 and Pankaj Malhotra, MD1

1Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Melissa Culhane Maravic1*, Natalie Land1*, Nadya Prood1*, Kelly Birch1*, Claire Cagle1*, Suepattra G. May1*, Eduardo J. Sabate2*, Ngozi Afulezi2*, Teraneh Z. Jhaveri2*, Mindy Chen2*, Audrey Hassan3*, Islam Sadek2 and Cosmina Hogea2*

1PRECISIONheor, New York, NY
2Gilead Sciences, Inc., Foster City, CA
3The MDS Foundation, Yardville, NJ

Marcelo Iastrebner, MD1*, Amer M. Zeidan, MBBS, MHS2, Jorge Arbelbide, PhD3*, Elvira Deolinda Rodrigues Pereira Velloso, MD, PhD4, Thales D.M. Pereira, MD5*, Matilde Boada, MD6*, Renee Crisp7*, Patricio Hernan Pereyra, PhD8*, Jheremy Reyes9,10*, Maria Helena Zappa11*, Fernando perez-Jacobo, MD12*, Jose Antonio Dela Peña Celaya13*, Emmanuel Martinez Moreno, MD14*, Virginia Abello, MD15,16*, Maria Elena Solano17,18*, Diana Cuervo, MD16,19,20*, Daniel Lorenzo Espinosa21,22*, Claudia Patricia Casas, MD23,24*, Leire Montoya13*, Alicia Enrico25*, Virginia Prates26*, Elia Ixel Apodaca Chavez, MD27*, Juan Ontiveros-Austria, MD28, Laura Kornblihtt29*, Andres Gomez-De Leon, MD30, Victoria Toledo31*, Luz Negri, MD32*, Juan Serrano33*, Alexia Sánchez34*, Ana Cecilia Rodriguez-Zuñiga34*, Mariana Stevenazzi35*, Valentina Goldschmidt36* and Sofia Grille, MD, PhD37*

1Sanatorio Sagrado Corazón, Buenos Aires, Argentina
2Section of Hematology, Department of Internal Medicine, Yale University School of Medicine - Yale Cancer Center, New Haven, CT
3Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
4Hematology and Transfusion Medicine, Hospital das Clinicas, Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil
5Universidade de São Paulo, São Paulo, Brazil
6Unidad Académica de Hematologia. Hospital de Clinicas. Facultad de Medicina. Universidad de la Republica, Montevideo, URY
7Hospital Nacional Prof. Alejandro, Posadas, Buenos Aires, Argentina
8Hospital Nacional A. Posadas, Buenos Aires, Argentina
9Clínica los Cobos, Bogotá, Colombia
10Clínica los Nogales, Bogotá, Colombia
11Clinica Los Nogales, Bogotá, Colombia
12Hospital Central Norte PEMEX, MExico city, Mexico
13Centro Medico Nacional 20 de Noviembre ISSSTE, Ciudad de México, Mexico
14Hospital General de México Dr Eduardo Liceaga, Ciudad de México., Mexico
15Hospital de San José -Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia
16Registro Epidemiológico de las Cohortes de Pacientes Diagnosticados con Neoplasias y Enfermedades Hematológicas en Colombia (RENEHOC), Bogotá, Colombia
17Hospital San José, COLOMBIA, COL
18Registro Epidemiológico de las Cohortes de Pacientes Diagnosticados con Neoplasias y Enfermedades Hematológicas en Colombia (RENEHOC), BOGOTA, COL
19Fundación Universitaria de Ciencias de la Salud, Bogota, Colombia
20Hospital de San José, Bogotá, Colombia
21Registro Epidemiológico de las Cohortes de Pacientes Diagnosticados con Neoplasias y Enfermedades Hematológicas en Colombia (RENEHOC), Bogota, COL
22Hospital de San José- Fundación Universitaria de Ciencias de la Salud, Bogota, Colombia
23Registro Epidemiológico de las Cohortes de Pacientes Diagnosticados con Neoplasias y Enfermedades Hematológicas en Colombia (RENEHOC), Bogota, Colombia
24Hospital de San José- Fundación Universitaria de Ciencias de la Salud, BOGOTA, COL
25Hospital Italiano La Plata, La Plata-Buenos Aires, ARG
26Hospital Italiano-La Plata, La Plata-Buenos Aires, ARG
27Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
28Hematology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
29Hospital de Clínicas José de San Martín, Buenos Aires, Argentina
30Universidad Autónoma de Nuevo León, Facultad de Medicina y Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Mexico, Monterrey, Mexico
31Hematología. CASMER, Rivera, URY
32Hospital Nacional Itaugua, Asuncion, PRY
33Clínica Cancerologica del Norte de Santander, Cucuta, Colombia
34Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico
35Mautone, Maldonado, URY
36Hospital Padre Hurtado y Hospital del Salvador, Santiago, CHL
37Unidad Academica de Hematologia. Hospital de Clinicas. Facultad de Medicina. Universidad de la Republica, Montevido, Uruguay

Chitresh Yadav1*, Manoj Unni, MD DM2*, Mobin Paul, M.D, D.M3*, Monisha Harimadhavan, MD DrNB4*, Rema Ganapathy, MBBS, DNB5*, Nikhil Krishna Haridas, MD DrNB6*, Sheejamol V.S., Senior Lecturer7*, Chitra Sreenaryanan, M.Sc Applied Electronics8*, Rashmi Yawalkar, DM9*, Ullas Mony, PhD10* and Neeraj Sidharthan, MD, MBBS, DM, DNB11

1Department of Clinical Haematology, Amrita Institute of Medical Sciences , Amrita Viswa Vidyapeetam Kochi, Kochi, India
2Amrita institute of Medical sciences, Amrita Vishwa Vidyapeetham, Kochi, India
3Department of Clinical Haematology & Hemato - Oncology, Rajagiri Hospital, Kochi, India
4Amrita institute of Medical sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
5Department of Clinical Haematology, Amrita Institute of Medical Sciences , Amrita Viswa Vidyapeetam, Ernakulam, India
6Department of Medical Oncology, Amrita institute of Medical sciences, Amrita Vishwa Vidyapeetham, Kochi, India
7Department of Biostatistics, Amrita institute of Medical sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
8Department of Clinical Haematology, Amrita institute of Medical sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
9Department of Clinical Haematology, Amrita Institute of Medical Sciences , Amrita Viswa Vidya peetam, Kochi, India
10Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India
11Department of Clinical Haematology and Bone Marrow Transplantation, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India

Sindhusha Veeraballi, MD1*, Yanwen Chen, PhD2*, Hetty E. Carraway, MD, MBA3, Aaron T. Gerds, MD, MS4, Moaath K. Mustafa Ali, MD, MPH5, Arooj Ahmed, MD1*, Anjali S. Advani, MD6, John C Molina, MD, MEd7, Sophia Balderman, MD7*, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP1, Sudipto Mukherjee, MD, PhD, MPH8 and Abhay Singh, MD, MPH9

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Cleveland Clinic, Cleveland, OH
3Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
4Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Leukemia Division, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
6Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
8Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
9Taussig cancer center, Cleveland Clinic, Cleveland Clinic, Cleveland, OH

Erica E Fortune1*, Kimberly Rogers, PhD2*, Caroline Lawrence3*, Claire Saxton, MBA3*, Victoria G Morris, PhD3*, Thomas W LeBlanc, MD4, Maria Sae-Hau, PhD5* and Melissa F Miller, PhD3*

1Research Department, Cancer Support Community, Philadelphia, PA
2Cancer Support Community, Philadelphia, PA
3Cancer Support Community, Washington, DC
4Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
5The Leukemia & Lymphoma Society, Rye Brook, NY

Seiichi Villalona, MD, MA1*, Xin Wang, MD2, Peter Gabriel, MD3*, Abigail Doucette4*, Shannon R McCurdy, MD2, Alexander Perl2, Selina M Luger, MD, FRCPC2, Noelle V. Frey, MD, MS2, Ximena Jordan Bruno, MD2, Elizabeth O Hexner, MD, MSTR2, Daria V Babushok, MD, PhD5, David L. Porter, MD2, Alison W Loren, MD2, Keith W Pratz, MD2 and Catherine Lai, MD6

1Division of General Internal Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA
2Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
3Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Department of Biostatistics, University of Pennsylvania, Perelman School of Medicine, Philadelphia
5Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
6Abramson Cancer Center, Georgetown University Hospital, Washington, DC

Lixin Kang, BA1*, Xiaomei Ma, MD, PhD1*, Nikolai A. Podoltsev, MD, PhD2, Jessica M. Stempel, MD3 and Rong Wang, PhD1*

1Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT
2Associate Professor of Medicine, Department of Hematology, Yale School of Medicine, New Haven, CT
3Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT

Ujjwal Karki, MBBS1, Pravash Budhathoki2*, Anish Shah3*, Bipin Ghimire, MBBS4*, Shyam K Poudel1 and Mohammad Muhsin Muhsin Chisti, MD5

1Corewell Health William Beaumont University Hospital, Royal Oak, MI
2Bronxcare Health System, BRONX, NY
3Bronxcare Health System, Mahottari, Nepal
4Henry Ford Hospital, Detroit, MI
5Bloomfield Oncology, Troy, MI

James M. Rossetti1*, Rushir Choksi2*, Purvi Suthar3*, Phoebe Davis4*, Anupama Vasudevan5*, Poras Dave5*, Varun Vaidya6*, Brandon Wang5* and Harvey I. Katzen, MD5

1Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA
2University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA
3CTI BioPharma Corp., a Sobi company, Seattle, WA
4CTI BioPharma Corp., a Sobi Company, Indianapolis, IN
5Integra Connect PrecisionQ, West Palm Beach, FL
6Integra Connect PrecisionQ, West Palm Beach

Thuy Ho, M.D.1*, Graeme Murray, M.D., Ph.D.1*, Juhi Gor, M.D.1*, Ian Bouligny, MD2 and Keri Maher, DO1

1Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Anoop K Enjeti, MBBS FRCPA MD MRCP1, Chun Yew Fong, MBBS, FRACP, FRCPA, PhD2, Francesco Castaldi, PhD MSc3*, Taliesha Paine, PhD3*, Donna Collett4* and Robert Morlock5*

1Calvary Mater Hospital, Waratah, NSW, AUS
2Austin Hospital, Heidelberg, Australia
3Otsuka Australia Pharmaceutical Pty Ltd, Chatswood, NSW, Australia
4Valeur Consulting Pty Ltd, Sydney, Australia
5YourCareChoice, Ann Arbor, MI, Ann Arbor, MI

Rebecca Bystrom, MD1*, Laura L. Fernandes, PhD2*, Joseph Wynne, MD, PhD3*, Dianne Pulte, MD4, Eric Hansen, MS2*, Andrew J. Belli, MPH2*, Anna Barcellos, MPH2*, Christina M. Zettler2*, Jonathon Vallejo, PhD1*, Kelly J Norsworthy, MD5, Angelo De Claro, MD6, Catherine Lerro, PhD4*, Marc R Theoret, MD1,7*, Ching-Kun Wang, MD2* and Donna Rivera, MS, PharmD1*

1US Food and Drug Administration, Silver Spring, MD
2COTA, Inc., New York, NY
3CDER, FDA, Silver Spring, MD
4FDA, Silver Spring, MD
5Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
6Food and Drug Administration, Silver Spring, MD
7U.S. Food and Drug Administration, Silver Spring, MD

Vamsi K. Kota, MD1, David Wei, PhD2*, Daisy Yang, PharmD, BCOP2*, Hela Romdhani, PhD3*, Dominick Latremouille-Viau, MSc3*, Annie Guérin, MS3* and Kejal Jadhav, MS2*

1Georgia Cancer Center at Augusta University, Augusta, GA
2Novartis Pharmaceuticals Corp., East Hanover, NJ
3Groupe d’analyse, Ltée, Montreal, QC, Canada

Rahul Banerjee, MD1,2, Kelly Brassil, PhD, MSN, RN3*, Trenton Grossfeld4*, Austin Barr, MPH5* and Andrew J. Cowan, MD2,6,7,8

1Fred Hutchinson Cancer Center, Seattle, WA
2Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
3Pack Health, A Quest Diagnostics Company, Houston, TX
4University of Washington, Department of Hematologic Malignancies, Seattle, WA
5Pack Health, A Quest Diagnostics Company, Birmingham, AL
6Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
7University of Washington, Seattle, WA
8Division of Medical Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA

*signifies non-member of ASH